Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Exp Neurol
    April 2026
  1. ZHANG SZ, Ma Y, Ding Y, Yin YQ, et al
    Astrocytic TPK1 mitigates amyloid pathology via TFEB-mediated endocytosis.
    Exp Neurol. 2026;398:115640.
    >> Share

    March 2026
  2. CHEN W, Huang N, Huang W, Wang M, et al
    TREM2 as a possible link between Alzheimer's disease and diabetes mellitus.
    Exp Neurol. 2026 Mar 18:115739. doi: 10.1016/j.expneurol.2026.115739.
    >> Share

  3. ZHAO Y, Chen W, Zhou F
    IL-1beta neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with hyperhomocysteinemia.
    Exp Neurol. 2026;401:115729.
    >> Share

  4. ZHU X, Lai X, Deng J, Long Y, et al
    Naturally occurring antibodies against ASC reduced in Alzheimer's disease and alleviating AD-type pathology in APP/PS1 mouse.
    Exp Neurol. 2026 Mar 15:115728. doi: 10.1016/j.expneurol.2026.115728.
    >> Share

  5. LI W, Chen S, Liu Z, Lei B, et al
    Differential effects and underlying mechanisms of voluntary, forced, and combined exercise on ameliorating Alzheimer's disease pathophenotypes.
    Exp Neurol. 2026;401:115731.
    >> Share

  6. KELLER M, Gallagher C, Marengo L, Bickenbach K, et al
    Meprin beta elevates hippocampal soluble Abeta in the APP/V717I mouse model.
    Exp Neurol. 2026;397:115600.
    >> Share

    February 2026
  7. LI J, Sun W, Guo S, Bai J, et al
    The role of IGF1 signaling in remote ischemic conditioning-mediated amelioration of Alzheimer's disease pathology and cerebral insulin resistance.
    Exp Neurol. 2026 Feb 18:115685. doi: 10.1016/j.expneurol.2026.115685.
    >> Share

  8. WU L, Hou F, Wang Z, Wu M, et al
    Mitochondrial calcium uniporter knockdown in hippocampal neurons effectively attenuates synaptic plasticity impairment and pathology in APP/PS1/tau model of Alzheimer's disease.
    Exp Neurol. 2026 Feb 11:115686. doi: 10.1016/j.expneurol.2026.115686.
    >> Share

  9. FARKAS S, Jasper V, Nyers-Marosi K, Petrovai B, et al
    Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a quadruple transgenic model.
    Exp Neurol. 2026;400:115684.
    >> Share

    January 2026
  10. VAN ROOIJ JRA, van den Berg M, Van Vosselen M, Calus E, et al
    Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimer's disease.
    Exp Neurol. 2026 Jan 14:115647. doi: 10.1016/j.expneurol.2026.115647.
    >> Share

    December 2025
  11. CHEN X, Yao H, Ma S, Zhu H, et al
    FGF22/FGFR2/YAP modulates ferroptosis to suppress neurodegeneration and cognitive impairment in Alzheimer's disease.
    Exp Neurol. 2025 Dec 31:115630. doi: 10.1016/j.expneurol.2025.115630.
    >> Share

  12. KAUR A, Singh S, Singh M, Silakari P, et al
    Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer's disease rat model: Synthesis, in-silico and in-vivo insights.
    Exp Neurol. 2025 Dec 31:115634. doi: 10.1016/j.expneurol.2025.115634.
    >> Share

  13. HEGNET E, Hakli S, Koivisto H, Miettinen PO, et al
    Age and sex dependent hippocampal neuronal hyperactivity in Alzheimer model mice.
    Exp Neurol. 2025 Dec 31:115632. doi: 10.1016/j.expneurol.2025.115632.
    >> Share

  14. FU J, Ding C, Li W, Lei J, et al
    ELAVL1 interacts with APP and promotes Abeta-induced apoptosis in Alzheimer's disease by activating Bcl-2/Bax signaling.
    Exp Neurol. 2025;398:115613.
    >> Share

  15. SUPASAI S, Suntaratti P, Odton M, Longji T, et al
    HMGB1 Box A gene therapy reverses cognitive and neuropathological features in AlCl(3)/D-galactose rat model of Alzheimer's disease.
    Exp Neurol. 2025 Dec 8:115583. doi: 10.1016/j.expneurol.2025.115583.
    >> Share

  16. PAN JZ, Yu MY, Tian MZ, Liu R, et al
    Calcaratarin D exerts neuroprotective effects in Alzheimer's disease mouse model by inhibiting CERT-mediated NF-kappaB pathway.
    Exp Neurol. 2025;397:115585.
    >> Share

    November 2025
  17. OKECHUKWU NG, Zaccone C, La Barbera L, Nobili A, et al
    Excitation-inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy.
    Exp Neurol. 2025 Nov 29:115581. doi: 10.1016/j.expneurol.2025.115581.
    >> Share

  18. ALTINDAG F, Bayir MH, Alhalboosi JKI, Yildizhan K, et al
    Syringic acid mitigates scopolamine-induced cognitive impairment by regulating PSD-95 and GSK-3beta and by preventing neurodegeneration in an Alzheimer-like rat model.
    Exp Neurol. 2025 Nov 17:115556. doi: 10.1016/j.expneurol.2025.115556.
    >> Share

  19. HEATH AM, Mojabi FS, Kraybill EP, Beard C, et al
    Comparison of treatment schedules on cognitive effects of rTMS in the 3xTg-AD model of Alzheimer's disease.
    Exp Neurol. 2025;396:115551.
    >> Share

  20. YAO M, Li Z, Lin Y, Cai H, et al
    Hyperbaric oxygen therapy ameliorates Alzheimer's disease pathology by restoration of mitophagy and suppressing neuroinflammation in 5xFAD mice.
    Exp Neurol. 2025 Nov 4:115534. doi: 10.1016/j.expneurol.2025.115534.
    >> Share

    October 2025
  21. ZHENG M, Zhang Q, Siebert HC, Loers G, et al
    Semaglutide attenuates Alzheimer's disease model progression by targeting microglial NLRP3 inflammasome-mediated neuroinflammation and ferroptosis.
    Exp Neurol. 2025 Oct 29:115537. doi: 10.1016/j.expneurol.2025.115537.
    >> Share

  22. YOUSEFI A, Karimani F, Delphi L, Ghahfarokhi MR, et al
    Modulation of the mediodorsal thalamus nitric oxide system ameliorated amnesia and medial prefrontal abnormal network activity in a streptozotocin-induced rat model of Alzheimer's disease.
    Exp Neurol. 2025 Oct 22:115524. doi: 10.1016/j.expneurol.2025.115524.
    >> Share

  23. VRBJAR N, Radosinska D, Radosinska J
    The involvement of Na,K-ATPase enzyme in the development of Alzheimer's disease.
    Exp Neurol. 2025 Oct 21:115526. doi: 10.1016/j.expneurol.2025.115526.
    >> Share

  24. KIM D, Shim K, Kim J, Ko G, et al
    Potential anti-amyloid beta oligomerization effects of PD166793 in Alzheimer's disease.
    Exp Neurol. 2025 Oct 13:115504. doi: 10.1016/j.expneurol.2025.115504.
    >> Share

  25. PANTIYA P, Chattipakorn N, Chattipakorn SC
    Exploring the role of CD147 in cerebrovascular and Alzheimer's pathologies: Insights into mechanisms and interventions.
    Exp Neurol. 2025;395:115498.
    >> Share

  26. GENG D, Yan Y, Liu A, Zheng W, et al
    Experimental and computational study of 40?Hz low-field magnetic stimulation modulating neural activity and pathology in a mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Oct 6:115494. doi: 10.1016/j.expneurol.2025.115494.
    >> Share

  27. ZHANG M, Hai S, Gao X, Cui Z, et al
    MYT1L promotes autophagy to ameliorate amyloid-beta pathology and cognitive deficits in Alzheimer's disease via Notch signaling pathway.
    Exp Neurol. 2025 Oct 6:115492. doi: 10.1016/j.expneurol.2025.115492.
    >> Share

  28. LI S, Zheng F, Liu S, Wu R, et al
    Physical exercise protects neurons from energy deficit and improves cognitive function by upregulating astrocytic Slc2a1 in Alzheimer's disease.
    Exp Neurol. 2025 Oct 6:115493. doi: 10.1016/j.expneurol.2025.115493.
    >> Share

  29. CHEN G, Zhang J, Dong A, Xiao L, et al
    AXL-mediate GEF-H1 phosphorylation was involved in microglia synapse phagocytosis in 5xFAD mice.
    Exp Neurol. 2025;392:115327.
    >> Share

    September 2025
  30. ONO K, Noguchi-Shinohara M, Yoshita M, Naiki H, et al
    Retraction Notice to "Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances -synuclein fibril formation in vitro" [Experimental Neurology 203 (2007) 579-583].
    Exp Neurol. 2025 Sep 10:115456. doi: 10.1016/j.expneurol.2025.115456.
    >> Share

    August 2025
  31. SU WS, Wu MT, Cheng IH, Yang FY, et al
    Low-intensity pulsed ultrasound enhances microglial-mediated Abeta clearance and synaptic preservation in an APP transgenic mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Aug 12:115420. doi: 10.1016/j.expneurol.2025.115420.
    >> Share

  32. KAYE S, Gold A, Lin D, Chen M, et al
    Hypercholesterolemia drives microglial dysfunction and weakens response to amyloid plaques.
    Exp Neurol. 2025;390:115272.
    >> Share

    July 2025
  33. AZMAL M, Paul JK, Prima FS, Haque ANMSNB, et al
    Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions.
    Exp Neurol. 2025;392:115374.
    >> Share

  34. ALVES RL, Goncalves A, Voytyuk I, Harrison DC, et al
    Behaviour profile characterization of PS19 and rTg4510 tauopathy mouse models: A systematic review and a meta-analysis.
    Exp Neurol. 2025;389:115234.
    >> Share

    June 2025
  35. FRENCH AR, Christian-Hinman CA
    Aromatase inhibition modulates intrinsic properties and excitability of hippocampal CA1 pyramidal cells in the APP/PS1 mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Jun 30:115365. doi: 10.1016/j.expneurol.2025.115365.
    >> Share

  36. HUNG WC, Sun WC, Su TC, Lee YJ, et al
    FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer's disease mouse model.
    Exp Neurol. 2025 Jun 23:115357. doi: 10.1016/j.expneurol.2025.115357.
    >> Share

  37. PENG XQ, Guo HS, Zhang X, Wu XY, et al
    TREM2 promotes hippocampal neurogenesis through regulating microglial M2 polarization in APP/PS1 mice.
    Exp Neurol. 2025;388:115205.
    >> Share

    May 2025
  38. VIJAYAN V, Siddique IA, Gupta S, Chopra EM, et al
    Osteocalcin modulates Abeta42 aggregation to aid in amyloid reduction in mouse models of Alzheimer's disease.
    Exp Neurol. 2025 May 27:115322. doi: 10.1016/j.expneurol.2025.115322.
    >> Share

  39. HE Q, Jiang L, Chao FL, Zhou CN, et al
    The role of LINGO-1 in regulating CB1R/TrkB signalling and GABAergic interneurons in Alzheimer's disease pathogenesis.
    Exp Neurol. 2025 May 27:115319. doi: 10.1016/j.expneurol.2025.115319.
    >> Share

    April 2025
  40. SIM AY, Kim JY, Lee YH, Lee JE, et al
    Neuroprotective roles of SGLT2 and DPP4 inhibitors: Modulating ketone metabolism and suppressing NLRP3 inflammasome in T2D induced Alzheimer's disease.
    Exp Neurol. 2025 Apr 26:115271. doi: 10.1016/j.expneurol.2025.115271.
    >> Share

  41. KERR NA, Bramlett HM, Sanchez-Molano J, Higueras AF, et al
    Stool-derived extracellular vesicles increase inflammasome signaling and regulate the gut-brain axis after stroke in Alzheimer's disease transgenic mice.
    Exp Neurol. 2025;390:115269.
    >> Share

  42. REN J, Wang Y, Wang Y, Zhang Y, et al
    Dynamic changes of hippocampal dendritic spines in Alzheimer's disease mice among the different stages.
    Exp Neurol. 2025 Apr 15:115266. doi: 10.1016/j.expneurol.2025.115266.
    >> Share

  43. ROZEBOOM A, Broekaart DWM, Anink JJ, Boonkamp L, et al
    Cellular expression of low-density lipoprotein receptor-related protein 1 and amyloid beta deposition in human and rat epileptogenic brain.
    Exp Neurol. 2025;386:115149.
    >> Share

    March 2025
  44. LIU TT, Yang X, Lei HP, Hu YT, et al
    Gastrodin alleviates Abeta(25-35)-induced glycolytic dysfunction via activating PI3K/AKT/BACH1 signaling in Alzheimer's disease models.
    Exp Neurol. 2025 Mar 22:115225. doi: 10.1016/j.expneurol.2025.115225.
    >> Share

  45. ALTUN S, Ozdemir S, Arslan H, Kiliclioglu M, et al
    Impact of long-term deltamethrin exposure on Alzheimer's-related neurodegeneration in rats.
    Exp Neurol. 2025;388:115223.
    >> Share

  46. WANG A, Zhang F, Zhang W, Gong J, et al
    PPM1D ameliorates Alzheimer's disease by promoting mitophagy.
    Exp Neurol. 2025 Mar 14:115218. doi: 10.1016/j.expneurol.2025.115218.
    >> Share

  47. DA SILVA EA, Faber J, Penitente AR, Fernandes J, et al
    Effects of resistance exercise on behavioral and molecular changes in transgenic female mice for Alzheimer's disease in early and advanced stages.
    Exp Neurol. 2025;388:115217.
    >> Share

    February 2025
  48. CARTER SKR, Tipton RK, Forman CM, Mosher AP, et al
    Glutamate stress in the caudal nucleus tractus solitarii (nTS): Impact on respiratory function and synaptic signaling in an Alzheimer's disease model.
    Exp Neurol. 2025;387:115190.
    >> Share

  49. RODRIGUEZ-LOPEZ A, Esteban D, Dominguez-Romero AN, Gevorkian G, et al
    Tg-SwDI transgenic mice: A suitable model for Alzheimer's disease and cerebral amyloid angiopathy basic research and preclinical studies.
    Exp Neurol. 2025;387:115189.
    >> Share

    January 2025
  50. YANG MX, Wang ZR, Zhang YL, Zhang ZN, et al
    Albumin antagonizes Alzheimer's disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation.
    Exp Neurol. 2025 Jan 19:115155. doi: 10.1016/j.expneurol.2025.115155.
    >> Share

  51. LIU S, Liu X, Ke M, Wang J, et al
    Sleep fragmentation impairs cognitive function and exacerbates Alzheimer's disease-related pathology in a mouse model by disrupting mitochondrial biogenesis.
    Exp Neurol. 2025;386:115153.
    >> Share

  52. LI M, Mo Y, Yu Q, Anayyat U, et al
    Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway.
    Exp Neurol. 2025;383:115029.
    >> Share

    December 2024
  53. KAUR R, Pandey S, Gupta S, Singh J, et al
    Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease.
    Exp Neurol. 2024;385:115134.
    >> Share

  54. FRANKLIN Z, Hull C, Delibegovic M, Platt B, et al
    Pharmacological PTP1B inhibition rescues motor learning, neuroinflammation, and hyperglycaemia in a mouse model of Alzheimer's disease.
    Exp Neurol. 2024;385:115115.
    >> Share

    November 2024
  55. WANG Y, Wu W, Zeng F, Meng X, et al
    The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer's disease.
    Exp Neurol. 2024;384:115070.
    >> Share

  56. EL-DESOUKY S, Abdel-Halim M, Fathalla RK, Abadi AH, et al
    A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease.
    Exp Neurol. 2024;384:115058.
    >> Share

  57. MERINO-SERRAIS P, Soria JM, Arrabal CA, Ortigado-Lopez A, et al
    Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease.
    Exp Neurol. 2024 Nov 8:115049. doi: 10.1016/j.expneurol.2024.115049.
    >> Share

    October 2024
  58. DHIMAN N, Deshwal S, Rishi V, Singhal N, et al
    Zebrafish as a model organism to study sporadic Alzheimer's disease: Behavioural, biochemical and histological validation.
    Exp Neurol. 2024 Oct 25:115034. doi: 10.1016/j.expneurol.2024.115034.
    >> Share

  59. ZHENG F, Dong T, Chen Y, Wang L, et al
    Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.
    Exp Neurol. 2024;383:115021.
    >> Share

  60. WANG X, Wang Q, Wang X, Zhao H, et al
    Early intervention using long-term rhythmic pulsed magnetic stimulation alleviates cognitive decline in a 5xFAD mouse model of Alzheimer's disease.
    Exp Neurol. 2024 Oct 15:115002. doi: 10.1016/j.expneurol.2024.115002.
    >> Share

    September 2024
  61. BALE LK, West SA, Gades NM, Baker DJ, et al
    Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model.
    Exp Neurol. 2024;382:114976.
    >> Share

    August 2024
  62. YE Y, Fu C, Li Y, Sun J, et al
    Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease.
    Exp Neurol. 2024 Aug 12:114920. doi: 10.1016/j.expneurol.2024.114920.
    >> Share

    July 2024
  63. BERETTI F, Gatti M, Ricchi F, Lipani F, et al
    Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression.
    Exp Neurol. 2024 Jul 30:114908. doi: 10.1016/j.expneurol.2024.114908.
    >> Share

  64. ZHAO Y, He C, Hu S, Ni H, et al
    Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3beta inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3beta/Nrf2 pathway.
    Exp Neurol. 2024 Jul 10:114881. doi: 10.1016/j.expneurol.2024.114881.
    >> Share

  65. LI CL, Zhou GF, Xie XY, Wang L, et al
    STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.
    Exp Neurol. 2024;377:114805.
    >> Share

    May 2024
  66. HUANG XY, Xue LL, Ma RF, Shi JS, et al
    Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment.
    Exp Neurol. 2024 May 29:114841. doi: 10.1016/j.expneurol.2024.114841.
    >> Share

  67. EL-ARABY RE, Wasif K, Johnson R, Tu Q, et al
    Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
    Exp Neurol. 2024 May 22:114820. doi: 10.1016/j.expneurol.2024.114820.
    >> Share

  68. ZHANG Y, Mu BR, Ran Z, Zhu T, et al
    Pericytes in Alzheimer's disease: Key players and therapeutic targets.
    Exp Neurol. 2024 May 20:114825. doi: 10.1016/j.expneurol.2024.114825.
    >> Share

  69. BARATI N, Shojaeian A, Ramezani M, Kalhori F, et al
    Investigating the effect of parasites (toxoplasma gondii RH strain, Leishmania major (MRHO/IR/75/ER), and hydatid cyst) antigens on Alzheimer's disease: An in vivo evaluation.
    Exp Neurol. 2024;377:114813.
    >> Share

    March 2024
  70. ZHUGE F, Zheng L, Pan Y, Ni L, et al
    DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice.
    Exp Neurol. 2024;373:114689.
    >> Share

  71. ZUO Y, Liu HT, Lin LB, Yue RZ, et al
    A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
    Exp Neurol. 2024;373:114657.
    >> Share

    February 2024
  72. ESHANI M, Anupam R, Raj SA, Ashish J, et al
    To evaluate the effect of endothelin receptor agonist IRL-1620 alone and in combination with donepezil in modulating neurodegeneration elicited by amyloid-beta in rats.
    Exp Neurol. 2024 Feb 9:114720. doi: 10.1016/j.expneurol.2024.114720.
    >> Share

    January 2024
  73. XU M, Li J, Xia L, Du Y, et al
    PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation.
    Exp Neurol. 2024 Jan 10:114688. doi: 10.1016/j.expneurol.2024.114688.
    >> Share

  74. YUBOLPHAN R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, et al
    Potential links between platelets and amyloid-beta in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies.
    Exp Neurol. 2024 Jan 9:114683. doi: 10.1016/j.expneurol.2024.114683.
    >> Share

  75. DEMBY T, Gross PS, Mandelblatt J, Huang JK, et al
    The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.
    Exp Neurol. 2024;371:114609.
    >> Share

    November 2023
  76. ISLA AG, Balleza-Tapia H, Chu F, Chen G, et al
    Low dose of levetiracetam counteracts amyloid beta-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity.
    Exp Neurol. 2023;369:114545.
    >> Share

    September 2023
  77. HOSSEININIA M, Rostami F, Delphi L, Ghasemzadeh Z, et al
    Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model.
    Exp Neurol. 2023 Sep 30:114560. doi: 10.1016/j.expneurol.2023.114560.
    >> Share

  78. UPADHYAY P, Gupta S
    Dual mode of Triphala in the reversal of cognition through gut restoration in antibiotic mediated prolonged dysbiosis condition in 5XFAD mice.
    Exp Neurol. 2023;367:114473.
    >> Share

    August 2023
  79. TIAN S, Ye T, Cheng X
    The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 x Tg-AD) mouse model strain.
    Exp Neurol. 2023 Aug 17:114505. doi: 10.1016/j.expneurol.2023.114505.
    >> Share

  80. HOSSAIN SR, Karem H, Jafari Z, Kolb BE, et al
    Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP (NL-G-F) adult offspring (NL-G-F/NL-G-F) mice.
    Exp Neurol. 2023 Aug 1:114498. doi: 10.1016/j.expneurol.2023.114498.
    >> Share

    June 2023
  81. DU K, Dou Y, Chen K, Zhao Y, et al
    Activation of TRPV4 induces intraneuronal tau hyperphosphorylation via cholesterol accumulation.
    Exp Neurol. 2023;364:114392.
    >> Share

    May 2023
  82. GHASEMI A, Qaffaripour Z, Tourani M, Saleki K, et al
    The relationship between long non-coding RNAs and Wnt/beta-catenin signaling pathway in the pathogenesis of Alzheimer's disease.
    Exp Neurol. 2023 May 16:114434. doi: 10.1016/j.expneurol.2023.114434.
    >> Share

  83. WANG YY, Zhou YN, Jiang L, Wang S, et al
    Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice.
    Exp Neurol. 2023;363:114371.
    >> Share

    April 2023
  84. JAFARI Z, Afrashteh N, Kolb BE, Mohajerani MH, et al
    Hearing loss and impaired short-term memory in an Alzheimer's disease mouse model of amyloid-beta pathology.
    Exp Neurol. 2023 Apr 17:114413. doi: 10.1016/j.expneurol.2023.114413.
    >> Share

  85. YANG YY, Ren YT, Jia MY, Bai CY, et al
    The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
    Exp Neurol. 2023;362:114346.
    >> Share

  86. WU SL, Yu B, Cheng YJ, Ren SY, et al
    Brain region-specific myelinogenesis is not directly linked to amyloid-beta in APP/PS1 transgenic mice.
    Exp Neurol. 2023;362:114344.
    >> Share

  87. LI L, Miao J, Jiang Y, Dai CL, et al
    Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice.
    Exp Neurol. 2023;362:114337.
    >> Share

    March 2023
  88. MEI Y, Li Y, Cheng YX, Gao L, et al
    The effect of gastric bypass surgery on cognitive function of Alzheimer's disease and the role of GLP1-SGLT1 pathway.
    Exp Neurol. 2023 Mar 7:114377. doi: 10.1016/j.expneurol.2023.114377.
    >> Share

  89. WANG C, Chang Y, Zhu J, Wu Y, et al
    AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Exp Neurol. 2023;363:114355.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016